Shipman & Goodwin has a multidisciplinary team of attorneys who represent companies in the bioscience industry, including biotechnology companies, medical device manufacturers, pharmaceutical companies, healthcare providers, tissue banks, software companies, investment banks and venture capital firms. Because our attorneys have backgrounds in both science and healthcare, we understand the scientific, business, and regulatory issues facing our clients.
We provide assistance to bioscience companies at every stage of development, from startup and emerging companies to late stage companies. We often work closely with special counsel on obtaining patents and FDA regulatory approvals. We also represent investment banks, venture capitalists, and other debt and equity investors in the industry. Our team can provide coordinated and efficient services to bioscience companies and other industry participants, including:
- regulatory guidance and compliance,
- strategic alliances, joint ventures, mergers, acquisitions and divestitures,
- research, development and commercialization of new products,
- license agreements,
- supply, marketing and distribution agreements,
- venture capital, equity investments and institutional financing,
- patent and commercial litigation,
- real estate and facilities,
- environmental,
- tax and tax exemption, and
- labor and employment.